Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 281
Filter
1.
Am J Pharm Educ ; 88(7): 100723, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38821189

ABSTRACT

From 2021 to 2023, 7978 graduates of pharmacy programs failed the North American Pharmacist Licensure Examination on the first attempt. Presently, the Accreditation Council for Pharmacy Education monitors programs with a passage rate of ≥ 2 SDs below the national mean pass rate. In 2023, this should lead to monitoring 7 programs that produced 140 failures out of the total of 2472 failures (5.7 %). In our view, this is neither equitable nor demonstrative of sufficient accountability. Analysis of failure counts among the 144 programs reported by the National Association of Boards of Pharmacy demonstrates a distribution curve highly skewed to the right. The evaluation of average failure counts across all programs suggests that schools with absolute failures ≥ 2 SDs higher than the average number of failures should be identified for monitoring, in addition to those falling ≥ 2 SDs below the national mean pass rate. Based on the 2023 data, this additional criterion corresponds to ≥ 35 failures/program. This threshold would prompt monitoring of 18 programs and 36.5 % of the total failures. Of the 7 programs that will be monitored based on the current Accreditation Council for Pharmacy Education criteria, only 1 would be captured by the ≥ 35 failure method of selection; the remaining 6 contribute 85 total failures to the pool. Thus, if both criteria were to be applied, ie, ≥ 35 failures and ≥ 2 SDs below the national mean pass rate, a total of 24 programs would be monitored (16.6 % of the 144 programs) that contribute 987 of the total failures (39.9 %).


Subject(s)
Accreditation , Education, Pharmacy , Educational Measurement , Licensure, Pharmacy , Pharmacists , Humans , Education, Pharmacy/standards , Educational Measurement/standards , Educational Measurement/methods , Educational Measurement/statistics & numerical data , Accreditation/standards , Pharmacists/standards , Pharmacists/statistics & numerical data , Schools, Pharmacy/standards , Schools, Pharmacy/statistics & numerical data , United States , North America , Students, Pharmacy
2.
Curr Pharm Teach Learn ; 16(6): 476-483, 2024 06.
Article in English | MEDLINE | ID: mdl-38604893

ABSTRACT

BACKGROUND AND PURPOSE: To investigate final-year student pharmacists' experiences of a new module for North American Pharmacist Licensure Examination® (NAPLEX®) preparation at one college of pharmacy in the United States. EDUCATIONAL ACTIVITY AND SETTING: All student pharmacists enrolled in a new Spring 2023 module for NAPLEX preparation (n = 118) were invited to complete an electronic questionnaire and participate in a semi-structured interview. The questionnaire investigated the perceived helpfulness, grading, importance, prioritization, structure, and timing of the module in the curriculum, as well as assignment choices, confidence building, and time management using a six-point Likert scale. Semi-structured interviews investigated experiences with NAPLEX modules, time management, and course format. Questionnaire data were descriptively analyzed; interview data were thematically analyzed. FINDINGS: Forty-one completed questionnaires and seven interviews were analyzed. Median scores for questionnaire items were six (denoting strongly agree) for three items, five (denoting agree) for seven items, and four (denoting somewhat agree) for two items. Twenty-three (56%) students desired an online self-directed (asynchronous) course structure. Seventeen (42%) students desired a mixture of short and long course assignments with a greater proportion of short course assignments while another 17 (42%) desired only short course assignments. Two themes were constructed from interviews: timing (when to study for NAPLEX) and structure (how to study for NAPLEX). SUMMARY: Study findings indicated typically positive perceptions of a module for NAPLEX preparation among final-year student pharmacists at a college of pharmacy in the United States. Recommendations from students can be used to improve the module in future years.


Subject(s)
Curriculum , Education, Pharmacy , Perception , Students, Pharmacy , Humans , Students, Pharmacy/statistics & numerical data , Students, Pharmacy/psychology , Curriculum/trends , Curriculum/standards , Surveys and Questionnaires , United States , Education, Pharmacy/methods , Education, Pharmacy/standards , Education, Pharmacy/statistics & numerical data , Male , Female , Educational Measurement/methods , Educational Measurement/statistics & numerical data , Adult , Interviews as Topic/methods , Licensure, Pharmacy/statistics & numerical data
3.
Am J Pharm Educ ; 88(5): 100701, 2024 May.
Article in English | MEDLINE | ID: mdl-38641172

ABSTRACT

As first-time pass rates on the North American Pharmacy Licensure Examination (NAPLEX) continue to decrease, pharmacy educators are left questioning the dynamics causing the decline and how to respond. Institutional and student factors both influence first-time NAPLEX pass rates. Pharmacy schools established before 2000, those housed within an academic medical center, and public rather than private schools have been associated with tendencies toward higher first-time NAPLEX pass rates. However, these factors alone do not sufficiently explain the issues surrounding first-time pass rates. Changes to the NAPLEX blueprint may also have influenced first-time pass rates. The number of existing pharmacy schools combined with decreasing numbers of applicants and influences from the COVID-19 pandemic should also be considered as potential causes of decreased first-time pass rates. In this commentary, factors associated with first-time NAPLEX pass rates are discussed along with some possible responses for the Academy to consider.


Subject(s)
COVID-19 , Education, Pharmacy , Educational Measurement , Licensure, Pharmacy , Schools, Pharmacy , Humans , Educational Measurement/standards , Schools, Pharmacy/standards , COVID-19/epidemiology , Students, Pharmacy , Pharmacists , United States
4.
J Am Pharm Assoc (2003) ; 64(3): 102031, 2024.
Article in English | MEDLINE | ID: mdl-38341088

ABSTRACT

BACKGROUND: Despite variation in licensure requirements and models for pharmacy practice nationwide, there is little published data within the United States regarding pharmacist perspectives. OBJECTIVES: The purpose of this study was to identify the demographics, awareness, and perceptions about current pharmacist licensure models. METHODS: A fifteen-question mixed-methods survey was created and distributed via Qualtrics-XM Survey to all Utah licensed pharmacists (n = 4154). Data collection was August 22-September 22, 2022. Before survey distribution, pilot feedback was sought from the Utah Board of Pharmacy and pharmacists at the 118th National Association of Boards of Pharmacy (NABP) national conference. Exempt status was granted by Roseman University Institutional Review Board. Quantitative and qualitative data analysis allowed for descriptive statistics and thematic content identification. RESULTS: The survey collected 972 responses for a response rate of 23% and a completion rate of 94%. Respondents self-identified 36 practice areas. Distribution of years in practice was well dispersed between the predefined ranges. Primary state of licensure was Utah (80%), with additional representation from all 50 states and Guam. The survey showed a variation in awareness regarding other healthcare professional licensing models with 40.83% "aware," 40.62% "unaware," and 18.55% "unsure". A majority showed awareness of the NABP Verify program (55.8%), but unawareness of the Electronic Licensure Transfer Program program (56.14%). Respondents agreed with increased license portability for medically underserved and rural areas (71.79%) and preference for having a law exam (56.72%). Pharmacists (n = 405) noted concerns regarding multistate renewal requirements, fees, and continuing education. CONCLUSION: This study provided baseline data on a topic that is missing in existing literature. Results illustrated a high completion rate, a diversity of demographics including well dispersed age ranges, years in practice, and qualitative responses. The quantitative data shed light on a variety of pharmacist perspectives and varied awareness about NABP licensure programs and compacts.


Subject(s)
Pharmacists , Humans , Pharmacists/statistics & numerical data , Surveys and Questionnaires , Female , Male , Adult , Utah , Middle Aged , Licensure, Pharmacy , United States , Attitude of Health Personnel , Pharmaceutical Services/organization & administration , Feedback , Licensure
5.
Am J Pharm Educ ; 88(2): 100642, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38185466

ABSTRACT

OBJECTIVES: The current study assessed how students prepared for the North American Pharmacist Licensure Examination (NAPLEX), and examined factors associated with first-time pass rates. In addition, updated information on student perceptions of several currently available NAPLEX preparation resources was collected. METHODS: A survey was administered to 2022 graduates from 1 school, which collected data on student demographics, and NAPLEX-related items regarding when the exam was taken and how students prepared, including resources used. The association between first-time success (pass, no pass) and grade point average (GPA), timing of test date after graduation, effort toward exam, and number of hours studied was examined. In addition, student ratings of NAPLEX preparation resources in terms of usefulness, representativeness to actual examination, and monetary value were reported. RESULTS: A total of 52 individuals completed the survey. Pharmacy GPA over 3.5, taking the NAPLEX within 60 days of graduation, and exerting moderate to extensive effort to pass the NAPLEX were all associated with higher first-time pass rates. All students reported using at least 1 RxPrep resource, which students rated highly and suggested the school provide as a resource for NAPLEX preparation. CONCLUSION: This study found that taking the NAPLEX examination within 60 days of graduation, contributing moderate to extensive effort to pass the examination, as well as a cumulative GPA of 3.5 (out of 4) or above were related to success on the NAPLEX. Additionally, students reported high satisfaction with RxPrep resources.


Subject(s)
Education, Pharmacy , Pharmacy , Students, Pharmacy , Humans , Pharmacists , Educational Measurement , Licensure, Pharmacy , Schools, Pharmacy
6.
Am J Pharm Educ ; 88(3): 100655, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38237686

ABSTRACT

OBJECTIVE: One of the final tasks for pharmacy graduates to enter practice is passing the North American Pharmacist Licensure Examination (NAPLEX). Given the recent national declines in pass rates, programs are making significant investments of time and money in NAPLEX preparation. The objective is to characterize the structure and content of required NAPLEX preparation courses. METHODS: A survey on NAPLEX preparation practices was developed and distributed to all Accreditation Council for Pharmacy Education-accredited pharmacy schools. NAPLEX preparation course syllabi were also collected as part of this survey. Syllabus information was summarized into 4 elements: course structure, content, resources, and assessment strategies. RESULTS: Of 144 colleges/schools of pharmacy, 100 responded to the survey, 87 reported having a NAPLEX preparation program, and 47 reported having a NAPLEX preparation course. Twenty syllabi were collected. Most courses (14) were longitudinal through the Advanced Pharmacy Practice Experiences year, 16 were credit-bearing, and 19 included a vendor NAPLEX preparatory product. Fourteen courses were hybrid delivery, and 12 focused on licensure preparation and included test-taking strategies, calculations practice, case-based discussions, etc. All 20 courses reported using unproctored timed quizzes and practice examinations, half conducted proctored timed assessments, and 11 included written reflections and/or continuous professional development activities. Most courses were pass/fail (15), and high stakes (16) were defined by delayed or withheld graduation as a consequence for failure. Only 3 of 20 NAPLEX preparation courses were mapped to NAPLEX competencies. CONCLUSION: Although required NAPLEX preparation courses focus on assessments, the content is infrequently mapped to NAPLEX competencies. This project provides some information on how schools might create their own NAPLEX preparatory courses.


Subject(s)
Education, Pharmacy , Pharmacy , Students, Pharmacy , Humans , Pharmacists , Educational Measurement , Licensure, Pharmacy , Schools, Pharmacy
7.
Curr Pharm Teach Learn ; 16(1): 1-4, 2024 01.
Article in English | MEDLINE | ID: mdl-38129217

ABSTRACT

INTRODUCTION: First-time pass rates of the North American Pharmacist Licensure Examination (NAPLEX) have declined 7% from 2019 to 2022 with more than a third of schools experiencing a decline of ≥10%. COMMENTARY: The cause of the decline is likely multifactorial and extends beyond the impact of the COVID-19 pandemic. Changes to the NAPLEX blueprint in 2021, curricular revisions in response to the implementation of Accreditation Council for Pharmacy Education Standards 2016, and changes to prerequisite course requirements in response to declining enrollment must also be evaluated as potential causes. IMPLICATIONS: The academy must respond to this decline by scrutinizing admissions, curriculum, and assessment processes. We urge the National Association of Boards of Pharmacy to provide access to student-level data on NAPLEX performance and increase transparency in passing standard practices to inform this process.


Subject(s)
Pharmacists , Students, Pharmacy , Humans , Educational Measurement , Accidental Falls , Pandemics , Licensure, Pharmacy
8.
An. R. Acad. Nac. Farm. (Internet) ; 89(3): 297-305, Juli-Sep. 2023. ilus
Article in English | IBECS | ID: ibc-226787

ABSTRACT

This study presents selected unpublished documents that concern the completion of the pharmacy degree programme and its corresponding qualifying exam, in accordance with the reforms of the Napoleonic Italian Republic (1802-1805) and the Napoleonic Kingdom of Italy (1805-1814). The Law on Public Education of 4 September 1802 and the Study and Discipline Plans for National Universities of 1803 stated that pharmacists had to study for three years at one of the national universities in order to obtain an academic degree. These reforms also declared that, after graduating, a further exam was required before pharmacists could freely exercise their profession.The first remarkable document is the one containing the oath taken by pharmacy students upon obtaining their academic degree. The oath is very detailed and accurately describes the expectations that the new Italian Government placed on pharmacists, as well as all the duties that they had to fulfil.Among the documents of the Ufficio Centrale Medico, Chirurgico, Farmaceutico (Central Medical, Surgical and Pharmaceutical Office) – the body that at the time was responsible for qualifying health professionals – there are the Office regulations, with all the rules concerning the pharmacists’ qualifying exam and their proclamation. There is also the oath formula that pharmacists read aloud at the end of their final exam. This oath was more concise than the oath taken at the end of university studies and, in this case, it was the same as the one taken by physicians and surgeons. What is also remarkable in these documents is the special qualification that was granted to those most deserving pharmacists who passed the exam with excellent marks: the possibility of producing and selling large quantities of chemical-pharmaceutical compounds to other pharmacists.(AU)


Este estudio presenta una selección de documentos inéditos relativos a la obtención del grado académico de farmacia y su correspondiente examen de habilitación, de acuerdo con las reformas de la República Italiana Napoleónica (1802-1805) y del Reino Napoleónico de Italia (1805-1814). La Ley de Instrucción Pública de 4 de septiembre de 1802 y los Planes de Estudio y Disciplina de las Universidades Nacionales de 1803 establecían que los farmacéuticos debían estudiar tres años en una de las universidades nacionales para obtener un título académico. Estas reformas también declaraban que, después de graduarse, se requería otro examen antes de que los farmacéuticos pudieran ejercer libremente su profesión.El primer documento destacable es el que contiene el juramento prestado por los estudiantes de farmacia al obtener su título académico. El juramento es muy detallado y describe con precisión las expectativas que el nuevo Gobierno italiano depositaba en los farmacéuticos, así como todas las obligaciones que debían cumplir.Entre los documentos del Ufficio Centrale Medico, Chirurgico, Farmaceutico (Oficina Central Médica, Quirúrgica y Farmacéutica), organismo que en aquella época se encargaba de habilitar a los profesionales sanitarios, se encuentra el reglamento del Ufficio, con todas las normas relativas al examen de habilitación de los farmacéuticos y su proclamación. También está la fórmula del juramento que los farmacéuticos leen al final de su examen final. Este juramento era más conciso que el que se prestaba al final de los estudios universitarios y, en este caso, era el mismo que el de los médicos y cirujanos. Lo que también llama la atención en estos documentos es la cualificación especial que se concedía a los farmacéuticos más meritorios que aprobaban el examen con excelentes notas: la posibilidad de producir y vender grandes cantidades de compuestos químico-farmacéuticos a otros farmacéuticos.(AU)


Subject(s)
Humans , Credentialing , Functioning License , Licensure, Pharmacy , Education, Pharmacy , History of Pharmacy , Pharmacy , Civil Codes , Pharmacists , History, 19th Century , Italy
9.
Am J Pharm Educ ; 87(12): 100580, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37531995

ABSTRACT

OBJECTIVE: Pharmacy colleges and schools invest substantial faculty effort and financial resources in North America Pharmacist Licensure Exam (NAPLEX) preparation, including vendor products purported to improve NAPLEX pass rates. The objective of this project was to examine NAPLEX preparation program characteristics associated with first-time pass rates. METHODS: A national survey investigated which pharmacy schools provided a formal NAPLEX preparation program in the 2021/2022 academic year, and what resources students were required to use. Pharmacy school characteristics and the unique resources provided in NAPLEX preparation programs were separately analyzed for association with 2022 NAPLEX first-time pass rates. RESULTS: The survey response rate was 71% (100 pharmacy schools). Of the 6 pharmacy school characteristics analyzed, offering a formal NAPLEX preparation program and private status were both weakly correlated with a decrease in the 2022 NAPLEX pass rate, while founding year of 2000 or earlier was weakly correlated with an increase in the pass rate. In a generalized linear model, a decrease in 2022 NAPLEX pass rate was associated with offering a formal NAPLEX preparation program (-5.90% [-11.55 to -0.23]) and with a 3-year accelerated curriculum (-9.15% [-15.55 to -2.75]). Of 12 resources required in NAPLEX preparation programs, 3 were weakly correlated with a decrease in 2022 pass rate: a vendor question bank, vendor review book/materials, and a live, synchronous faculty-led review. In a generalized linear model, a decrease in 2022 NAPLEX pass rate was associated with a live, synchronous faculty-led review (-6.62% [-11.16 to -2.08]). Among schools without a formal preparation program, NAPLEX pass rates consistently exceeded the national average in 2020, 2021, and 2022, while the proportion of schools with NAPLEX preparation programs and first-time pass rates above the national average dropped from 59% in 2021 and 58% in 2020 to 44% in 2022. CONCLUSION: Simply implementing a NAPLEX preparation program is insufficient to overcome other systemic/programmatic influences of successfully passing the NAPLEX; programs should invest earlier resources to address NAPLEX competencies.


Subject(s)
Education, Pharmacy , Students, Pharmacy , Humans , Pharmacists , Educational Measurement , Licensure, Pharmacy , North America , Schools, Pharmacy
10.
Curr Pharm Teach Learn ; 15(10): 854-860, 2023 10.
Article in English | MEDLINE | ID: mdl-37544784

ABSTRACT

INTRODUCTION: We have evaluated two approaches of monitoring schools and colleges of pharmacy based on North American Pharmacist Licensure Examination (NAPLEX) passage rates. Historically, the Accreditation Council for Pharmacy Education (ACPE) has cited programs for passage rate ≥2 SD below the national average. Since the National Association of Boards of Pharmacy (NABP) no longer reports scores, this procedure is being reconsidered. Our supposition is that the failure rate of ≥2 SD below the average should be retained, but now be based on the national average passage rate rather than score. Yet, we further suggest this is not sufficient due to major variations in class size. COMMENTARY: We suggest the establishment of a "maximum acceptable failure count," likely in the range of 20 to 25 failing graduates per class. Analyses of data from 2017 to 2019 indicate that this approach would lead to monitoring approximately 15% of existing programs that graduate approximately 40% of individuals failing NAPLEX vs. monitoring only 5% of programs that graduate approximately 9% of individuals failing NAPLEX. IMPLICATIONS: The historical method of monitoring pharmacy programs with NAPLEX passage rates ≥2 SD below the national average is not sufficient, primarily due large variations in class size. Since accreditation standards are currently being revised ("Standards 2025"), this would be an ideal time to update methods for selecting programs that warrant monitoring based on inadequate NAPLEX passage rates. We suggest the concept of "maximum acceptable failure count" should be considered when identifying programs to be cited.


Subject(s)
Pharmacy , Students, Pharmacy , Humans , Pharmacists , Educational Measurement/methods , Licensure, Pharmacy , Universities
11.
Pharm. pract. (Granada, Internet) ; 21(2): 1-9, abr.-jun. 2023. tab, graf, ilus
Article in English | IBECS | ID: ibc-222797

ABSTRACT

Objective: To study the licensee’s factors that affect the GPP compliance, including problems and obstacles in the improvement of pharmacies. Methods: Samples: 90 of the licensees of the modern pharmacies in Nakhon Ratchasima province that did not pass the GPP evaluation. A cross-sectional analytical research with mixed method was done with 2 parts 1) questionnaire survey to assess the attitude, perception, and perceived difficulty of the GPP based on Theory of planned behavior (TPB). The response rate at 68.89%. 2) Focus group discussion to find the problems and obstacles in pharmacy improvement to meet the GPP requirement. Results: the licensees who were a pharmacist have more compliance with the GPP than the non-pharmacist licensees (p=0.001), and the open on daytime period pharmacies (≥8 hours/day) have more compliance with the GPP than pharmacies that are open for certain hours (p=0.001). Attitude, perception and perceived difficulty of GPP from survey and focus group discussion could use as inputs for initiating an empowerment plan for pharmacy licensees. Conclusion: For the reasons that have more tendency to comply with the GPP than others, the pharmacists should be promoted to be the licensees, as well as responsible for operating the pharmacies. The pharmacy should have a pharmacist stationed 8 hours/day to provide the customers with professional standard service. (AU)


Subject(s)
Humans , Pharmacies , Pharmacists , Surveys and Questionnaires , Focus Groups , Cross-Sectional Studies , Licensure, Pharmacy , Thailand
12.
Am J Pharm Educ ; 87(2): ajpe8894, 2023 03.
Article in English | MEDLINE | ID: mdl-35396214

ABSTRACT

Objective. Remediation is a tool that allows students to correct an academic deficiency after earning an unsatisfactory grade. There is a lack of data on remediation processes and their impact on future academic performance. This study aimed to evaluate the impact of remediation frequency on North American Pharmacist Licensure Examination (NAPLEX) performance.Methods. The primary analysis was the relationship between the NAPLEX first-time pass rate and the frequency of course remediations (no remediations, one remediation, and two or more remediations). Additional analyses included the correlation between the NAPLEX scaled score and the number of course remediations and characteristics of the course remediated.Results. A total of 116 students with NAPLEX data were included for analysis. Compared to students who never remediated, NAPLEX first-time pass rates were similar among those who remediated only one course; however, students who remediated two or more courses had significantly lower NAPLEX pass rates. Remediation in courses mapped to Pharmacy Curriculum Outcomes Assessment (PCOA) area 4.0 (clinical sciences), and courses with mixed PCOA content areas were negatively correlated with NAPLEX scaled scores. A significant negative correlation existed between remediation in students' second or third years in pharmacy school and the NAPLEX scaled score, but this correlation was not significant for students in their first year.Conclusion. Multiple course remediations are negatively correlated with NAPLEX scaled scores and a reduced first-time NAPLEX pass rate, but a single course remediation has no effect. Institutions should aim to evaluate their current remediation practices and assess whether additional support should be provided to students with multiple course remediations.


Subject(s)
Education, Pharmacy , Students, Pharmacy , Humans , Educational Measurement/methods , Pharmacists , Education, Pharmacy/methods , Licensure, Pharmacy , Curriculum , North America
13.
Am J Pharm Educ ; 87(3): ajpe8994, 2023 04.
Article in English | MEDLINE | ID: mdl-35840140

ABSTRACT

Objective. To estimate whether first-time pass rates on the North American Pharmacist Licensure Examination (NAPLEX) have been influenced by the number of pharmacy programs founded since 2000, the programs' accreditation era, and the changes to the blueprint as well as changes to the testing conditions and passing standards implemented by the National Association of Boards of Pharmacy (NABP) beginning in 2015.Methods. This was a retrospective, observational cohort study using publicly published data. The number of programs and pass rates were collected from 2008 to 2020. Programs reporting pass rates from 2016 to 2020 were eligible. Accreditation era was defined as programs accredited before or after 2000. Pass rates were categorized into NAPLEX tests administered before or after 2015. Statistical analyses were conducted for comparisons.Results. Pass rates were initially found to decline as the number of programs rose. First-time pass rates of programs accredited before 2000 were higher than pass rates of programs accredited after 2000 every year after 2011. Only 40% of the programs accredited after 2000 exceeded the national average between 2016-2020. Blueprint changes implemented in 2015 and the changes to testing conditions plus passing standards implemented in 2016 had a greater effect on pass rates than the number of programs or applicants.Conclusion. Programs accredited after 2000 generally had lower first-time NAPLEX pass rates. Even so, blueprint changes and changes to the testing conditions plus passing standards instituted by the NABP were more important predictors of the decline of first-time NAPLEX pass rates. Stakeholders should collaborate and embrace best practices for assessing practice-ready competency for licensure.


Subject(s)
Education, Pharmacy , Students, Pharmacy , Humans , Pharmacists , Educational Measurement/methods , Education, Pharmacy/methods , Cohort Studies , Licensure, Pharmacy , Accreditation , North America , Licensure
14.
Curr Pharm Teach Learn ; 14(12): 1525-1534, 2022 12.
Article in English | MEDLINE | ID: mdl-36400707

ABSTRACT

BACKGROUND AND PURPOSE: Objective structured clinical examinations (OSCEs) are widely used, including in licensure examinations. OSCEs assess diverse skills in a structured manner, but can be stressful for students and have a significant organisational burden for faculty. Case-based video OSCE preparation resources were developed for students preparing for a licensure OSCE. The study aimed to examine student engagement, compare scores awarded by students to performances at specific competence standards with faculty scores, and examine usability, usefulness, and acceptability of the video cases. EDUCATIONAL ACTIVITY AND SETTING: Final year pharmacy students (n = 149) enrolled in an integrated master of pharmacy programme in Ireland were invited to participate. Six sets of recorded OSCE-based video cases were developed, comprising multiple recordings of the same case scenario, with each pitched at a different level of performance. Students watched and scored the video cases. Usability, usefulness, and acceptability were evaluated via questionnaire. FINDINGS: One or more video cases were accessed by 70.5% of students. Score ratings awarded by the students, when compared to faculty ratings, showed an overall trend towards inter-rater agreement between students and faculty. Students felt positively in terms of the usability, usefulness, and acceptability of the videos. SUMMARY: Video cases designed to support OSCE preparation for a high-stakes national pharmacy licensure examination were widely used by students and were perceived to be usable, useful, and acceptable. Such video cases may be a feasible alternative to additional mock OSCEs to support student preparation.


Subject(s)
Pharmaceutical Services , Pharmacy , Students, Pharmacy , Humans , Faculty , Licensure, Pharmacy
15.
Am J Pharm Educ ; 86(6): 8760, 2022 08.
Article in English | MEDLINE | ID: mdl-34785497

ABSTRACT

Objective. The objectives of this study were to (1) describe characteristics of preparation programs for the North American Pharmacist Licensure Examination (NAPLEX) that are currently used by colleges and schools of pharmacy and (2) evaluate these program characteristics in relation to first-attempt NAPLEX pass rates.Methods. This cross-sectional study was based on an online survey administered between February and March 2020. Assessment leads from 143 PharmD programs were invited to answer questions on their schools' PharmD program characteristics and various aspects of NAPLEX preparation programs. The study included regression analyses to investigate associations between the NAPLEX first-attempt pass rates and PharmD demographic characteristics as well as between first-attempt pass rates and various aspects of the NAPLEX preparation programs. Finally, common themes from open-ended questions were identified.Results. Fifty-eight participants completed the survey out of 132 successfully delivered email invitations (response rate = 44%). Fifty participants (86%) indicated that their PharmD program offers a NAPLEX preparation program. Our data indicate that offering a NAPLEX preparation program was not significantly associated with higher NAPLEX first-attempt pass rates. The analysis identified possible explanations for this lack of association, including student concerns with balancing a preparation program with advanced pharmacy practice experiences (APPEs) and the faculty workload associated with delivering such programs.Conclusion. The current findings show no association between offering a NAPLEX preparation program and NAPLEX first-attempt pass rates. Future research should continue to examine the impact of these programs on individual school pass rates and factors that may enhance student motivation to engage in these programs.


Subject(s)
Education, Pharmacy , Students, Pharmacy , Cross-Sectional Studies , Education, Pharmacy/methods , Educational Measurement/methods , Humans , Licensure, Pharmacy , Pharmacists , Schools, Pharmacy
16.
Clin Pharmacol Ther ; 110(5): 1381-1388, 2021 11.
Article in English | MEDLINE | ID: mdl-34383294

ABSTRACT

Immunogenicity, the potential to elicit an antidrug immune response, is a critical concern in developing biological products, but its consequences are difficult to predict with animal studies. The aims of the present study are to investigate the evolution of immunogenicity information in labeling and to identify attributes associated with immunogenicity labeling updates. Biologics License Applications (BLAs) approved by the Center for Drug Evaluation and Research, US Food and Drug Administration between 2008 and 2017 were studied. A majority of BLAs described the incidence/prevalence of antidrug antibodies (ADAs) (94.9%) and neutralizing antibodies (NAbs) (68.4%) in their original labeling documents. However, less than one third of the BLAs mentioned the impact of ADAs/NAbs in the original (20.3%) and most recent (29.1%) labeling documents. BLAs with a priority review status (57.4% vs. 33.3%), orphan designation (61.5% vs. 34.2%), or a mention of ADA impact in the latest label (69.6% vs. 38.9%) had higher percentages of applications with postmarketing requirements (PMRs) directly related to immunogenicity concerns in comparison with applications without those characteristics. Among the BLAs with updated immunogenicity information, the mean time to the first update was 1,077 days, while that for BLAs with accelerated approval was shorter (709.1 ± 492.2 days vs. 1173.8 ± 661.8 days). The results suggest that there is a substantial amount of critical information lacking in the original labeling documents and an overdependence on PMRs for more evidence. Additional efforts should be made to investigate the impact of ADAs to provide timely information for improved patient care.


Subject(s)
Biological Products/immunology , Drug Approval/methods , Drug Labeling/methods , Immunogenetic Phenomena , Licensure, Pharmacy , United States Food and Drug Administration , Drug Approval/legislation & jurisprudence , Drug Labeling/legislation & jurisprudence , Humans , Licensure, Pharmacy/legislation & jurisprudence , United States , United States Food and Drug Administration/legislation & jurisprudence
17.
JAMA Netw Open ; 4(7): e2116551, 2021 07 01.
Article in English | MEDLINE | ID: mdl-34251442

ABSTRACT

Importance: As global jurisdictions shift toward cannabis legalization, 2 areas of public health importance relate to exposure to youth and to truthful promotion. Although Canada's Cannabis Act specifies many prohibitions related to cannabis promotion, no systematic monitoring or enforcement among licensed firms exists. Compliance with marketing regulations has effects beyond Canadian citizens because of the global outreach of websites and social media. Objectives: To evaluate compliance among licensed firms with the Cannabis Act and analyze trends among violations regarding promotional material. Design, Setting, and Participants: This cross-sectional study evaluated cannabis-licensed firms after cannabis legalization. Data were extracted from online public platforms, including company websites, Facebook, Instagram, and Twitter, from October 1, 2019, to March 31, 2020. Descriptive statistics, Poisson regression, and logistic regression were used to analyze the associations of covariates with promotion violations. Main Outcomes and Measures: The primary outcome was characterization of type and prevalence of promotion violations. Secondary outcomes were the role of various covariates (namely, licensed firm characteristics and online platforms) in the frequency and probability of violations. Hypotheses were formulated before data collection. Results: Among 261 licensed firms, 211 (80.8%) had an online platform, including 204 (96.7%) with websites, 128 (60.7%) with Facebook, 123 (58.3%) with Instagram, and 123 (58.3%) with Twitter. Of all licensed firms with an online platform, 182 (86.3%) had at least 1 violation. Compared with websites, the risk of violations was significantly higher on Facebook (rate ratio [RR], 1.24; 95% CI, 1.11-1.39) and Instagram (RR, 1.19; 95% CI, 1.05-1.34). The most common violations included lack of age restrictions, brand glamorization, and omission of risk information. With websites as the reference group, lack of age restrictions was approximately 15 times more likely to occur on Facebook (odds ratio [OR], 14.76; 95% CI, 8.06-27.05); the odds of an age restriction violation were also higher on Instagram (OR, 2.48; 95% CI, 1.43-4.32) and Twitter (OR, 4.03; 95% CI, 2.29-7.09). For unsubstantiated claims, the odds of violations were significantly decreased on Facebook (OR, 0.23; 95% CI, 0.11-0.48) and Instagram (OR, 0.28; 95% CI, 0.14-0.57). The odds of glamorization were associated with an increase on Instagram (OR, 2.90; 95% CI, 1.72-4.88). Conclusions and Relevance: In this cross-sectional study, widespread violations were observed in online Canadian cannabis promotion. To protect public health and safety amid legalization, decision-makers should make explicit federal regulation and enforcement regarding promotional activities of cannabis retailers. These results suggest that policy and enforcement of cannabis promotion in Canada would have an international impact, from ease of access to online media and downstream consequences of unregulated promotion.


Subject(s)
Drug Industry/statistics & numerical data , Guideline Adherence/statistics & numerical data , Legislation, Drug/statistics & numerical data , Marketing/legislation & jurisprudence , Medical Marijuana , Canada , Cross-Sectional Studies , Drug Industry/legislation & jurisprudence , Humans , Internet/legislation & jurisprudence , Licensure, Pharmacy/legislation & jurisprudence
18.
Am J Pharm Educ ; 84(9): ajpe7827, 2020 09.
Article in English | MEDLINE | ID: mdl-33012794

ABSTRACT

Objective. To compare Pharmacy Curriculum Outcomes Assessment (PCOA) scaled scores and North American Pharmacist Licensure Examination (NAPLEX) pass rates in students who completed a two-week intersession remediation or repeated a course with the scaled scores and pass rates of students who did not require any form of didactic remediation and did not have to repeat a course. Methods. Data examined for this study included NAPLEX/PCOA scores, NAPLEX pass/fail status, and remediation history for students at one college of pharmacy. Students from the graduating classes of 2016, 2017, and 2018 were organized into four groups: non-remediation, one course remediation and no repeats, more than one course remediation and no repeats, and one or more course repeats. Differences were analyzed using linear regression, logistic regression, and Pearson correlations. Results. The PCOA scores for students in the remediation groups were significantly lower than scores for students in the non-remediation groups, with a reduction of 37.8 to 50.9 points from the expected non-remediators' score. The NAPLEX scores for students who remediated more than one course or repeated one or more courses were 16-20 points lower compared to students who did not remediate. The likelihood of a student failing the NAPLEX was also not significantly lower for students who remediated one course but was significantly lower for other remediation groups. Conclusion. Although single course remediation in this curricular model appears to have minimal impact on NAPLEX outcomes and may be an acceptable intervention for many students, additional support and interventions may be warranted for students who qualify for remediation in multiple courses and/or for repeating a course.


Subject(s)
Curriculum , Education, Pharmacy , Educational Measurement , Licensure, Pharmacy , Outcome Assessment, Health Care , Humans
19.
Am J Pharm Educ ; 84(8): ajpe847712, 2020 08.
Article in English | MEDLINE | ID: mdl-32934393

ABSTRACT

Objective. To examine the effect size of third professional (P3) year students' grade point average (GPA) on Pharmacy Curriculum Outcomes Assessment (PCOA) scores and to summarize the effect size of PCOA scores on North American Pharmacist Licensure Examination (NAPLEX) scores. Methods. To accomplish the objective, meta-analyses were conducted. For inclusion in the meta-analysis, studies were required to compare PCOA scores to and report data that permitted calculation of a numeric effect size for the chosen outcome variables. Multiple databases were searched, including PubMed, CINAHL, EMBASE, ProQuest Dissertations and Thesis (abstract limited), Academic Search Complete, and Google Scholar. Correlations were used as the effect size metric for all outcomes. All analyses used an inverse variance weighted random effects model. Study quality was reviewed for each study included in the meta-analyses. Results. This study found that PCOA scores were moderately correlated with P3 GPAs, accounting for 14% to 48% of the variability in PCOA scores. The meta-analyses also showed that PCOA scores were moderately correlated with NAPLEX and accounted for 25% to 53% of the variability in NAPLEX scores. Both meta-analyses showed a high degree of heterogeneity and many studies included were of low quality. Conclusion. This first set of meta-analyses to be conducted on the PCOA showed that third professional year GPA does correlate with PCOA results and that PCOA scores correlate with NAPLEX results. Though there are significant limitations to interpretation of the results, these results do help further elucidate the role of the PCOA as a benchmark of progress within the pharmacy curriculum.


Subject(s)
Education, Pharmacy/methods , Education, Pharmacy/statistics & numerical data , Educational Measurement/statistics & numerical data , Licensure, Pharmacy/statistics & numerical data , Outcome Assessment, Health Care/statistics & numerical data , Students, Pharmacy/statistics & numerical data , Curriculum/statistics & numerical data , Humans , Outcome Assessment, Health Care/methods , Pharmacists/statistics & numerical data , Pharmacy/methods , Reference Standards , Schools, Pharmacy/statistics & numerical data
20.
Am J Pharm Educ ; 84(6): ajpe8150, 2020 06.
Article in English | MEDLINE | ID: mdl-32665723

ABSTRACT

Academic institutions work diligently each year to recruit, retain, and graduate Doctor of Pharmacy (PharmD) students who will be positive contributors to our healthcare system. The immergence of a novel coronavirus in 2019 (COVID-19) has threatened these systems. This commentary is a discussion of the effects of the COVID-19 pandemic on the enrollment management processes of PharmD degree programs, including recruitment, admissions, orientation, retention, and graduation. The authors highlight enrollment management processes that may forever be changed by the COVID-19 pandemic. This commentary is intended to assist pharmacy administrators as they reflect on the impact of the COVID-19 pandemic on their own programs and develop strategies to minimize the negative effects.


Subject(s)
Coronavirus Infections/epidemiology , Education, Pharmacy/organization & administration , Personnel Selection/organization & administration , Pneumonia, Viral/epidemiology , Schools, Pharmacy/organization & administration , Betacoronavirus , COVID-19 , Education, Pharmacy/standards , Humans , Licensure, Pharmacy/standards , Pandemics , Personnel Selection/standards , SARS-CoV-2 , School Admission Criteria , Schools, Pharmacy/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...